(Q45254469)
Statements
Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: a multicentric Turkish Oncology Group (TOG) trial (English)
P Saip
Y Eralp
F Sen
H Karaca
M Ozkan
B Cetin
M Kucukoner
A Isikdogan
O Un
G Basaran